| GO | Name | 
		| GO:0000902 | cell morphogenesis | 
		| GO:0002042 | cell migration involved in sprouting angiogenesis | 
		| GO:0002092 | positive regulation of receptor internalization | 
		| GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 
		| GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 
		| GO:0005125 | cytokine activity | 
		| GO:0005615 | extracellular space | 
		| GO:0006915 | apoptotic process | 
		| GO:0007165 | signal transduction | 
		| GO:0007267 | cell-cell signaling | 
		| GO:0008284 | positive regulation of cell population proliferation | 
		| GO:0009887 | animal organ morphogenesis | 
		| GO:0009954 | proximal/distal pattern formation | 
		| GO:0009986 | cell surface | 
		| GO:0010717 | regulation of epithelial to mesenchymal transition | 
		| GO:0016015 | morphogen activity | 
		| GO:0030199 | collagen fibril organization | 
		| GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity | 
		| GO:0030308 | negative regulation of cell growth | 
		| GO:0030326 | embryonic limb morphogenesis | 
		| GO:0030502 | negative regulation of bone mineralization | 
		| GO:0030514 | negative regulation of BMP signaling pathway | 
		| GO:0032331 | negative regulation of chondrocyte differentiation | 
		| GO:0033689 | negative regulation of osteoblast proliferation | 
		| GO:0036122 | BMP binding | 
		| GO:0038098 | sequestering of BMP from receptor via BMP binding | 
		| GO:0042803 | protein homodimerization activity | 
		| GO:0043066 | negative regulation of apoptotic process | 
		| GO:0043184 | vascular endothelial growth factor receptor 2 binding | 
		| GO:0045668 | negative regulation of osteoblast differentiation | 
		| GO:0045766 | positive regulation of angiogenesis | 
		| GO:0045892 | negative regulation of transcription, DNA-templated | 
		| GO:0045944 | positive regulation of transcription by RNA polymerase II | 
		| GO:0046851 | negative regulation of bone remodeling | 
		| GO:0048018 | receptor ligand activity | 
		| GO:0048263 | determination of dorsal identity | 
		| GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 
		| GO:0051893 | regulation of focal adhesion assembly | 
		| GO:0051973 | positive regulation of telomerase activity | 
		| GO:0060173 | limb development | 
		| GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 
		| GO:0060676 | ureteric bud formation | 
		| GO:0062023 | collagen-containing extracellular matrix | 
		| GO:0090027 | negative regulation of monocyte chemotaxis | 
		| GO:0090090 | negative regulation of canonical Wnt signaling pathway | 
		| GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 
		| GO:0090291 | negative regulation of osteoclast proliferation | 
		| GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation | 
		| GO:1900155 | negative regulation of bone trabecula formation | 
		| GO:1900158 | negative regulation of bone mineralization involved in bone maturation | 
		| GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 
		| GO:2000273 | positive regulation of signaling receptor activity | 
		| GO:2000727 | positive regulation of cardiac muscle cell differentiation |